Gleason Score

What is a Gleason Score?

The Gleason score is a grading system used to evaluate how aggressive prostate cancer may be. It is determined by examining prostate tissue samples from a biopsy under a microscope and analyzing the patterns of cancer cells. By studying how abnormal the cells appear compared to normal prostate tissue, physicians can estimate how likely the cancer is to grow and spread. This information plays an important role in guiding treatment decisions and determining the most appropriate management plan.

Understanding the Gleason Score

The Gleason grading system was developed by Dr. Donald Gleason in the 1960s and remains one of the most important tools used in prostate cancer diagnosis and risk assessment. The system focuses on identifying patterns in prostate cancer cells and assigning grades based on how abnormal those cells appear.

Two patterns are evaluated in each biopsy sample:

• The primary pattern, which represents the most common type of cancer cells present

• The secondary pattern, which represents the second most common pattern observed

Each pattern is assigned a grade on a scale from 1 to 5:

• Grade 1: Cells look very similar to normal prostate tissue

• Grade 5: Cells appear highly abnormal and poorly organized

The two grades are then added together to produce the Gleason score.

Although the original scoring system ranges from 2 to 10, grades 1 and 2 are rarely used today because they closely resemble noncancerous tissue. As a result, most prostate cancer diagnoses fall within a Gleason score range of 6 to 10.

Interpreting Gleason Scores

Gleason Score 6 (3 + 3)
This score represents low-grade prostate cancer. The cancer cells are considered well-differentiated and tend to grow slowly. Many men with this score may be candidates for active surveillance, meaning the cancer is closely monitored rather than treated immediately.

Gleason Score 7 (3 + 4 or 4 + 3)
This is considered intermediate-grade cancer. The order of the numbers matters:

• 3 + 4 generally indicates a less aggressive cancer

• 4 + 3 suggests a higher proportion of more abnormal cells and may behave more aggressively

Gleason Scores 8–10
These scores indicate high-grade prostate cancer, meaning the cells are poorly differentiated and more likely to grow and spread quickly. In these cases, more aggressive treatment may be recommended.

Why the Gleason Score Matters

Understanding the Gleason score helps physicians determine how serious a prostate cancer diagnosis may be and what treatment options are most appropriate. The score is typically considered along with other factors such as PSA levels, imaging results, and the stage of the cancer.

Depending on the Gleason score and overall risk profile, treatment recommendations may range from active surveillance for low-risk disease to surgery, radiation therapy, hormone therapy, or other treatments for more aggressive cancers.

By providing insight into how prostate cancer is likely to behave, the Gleason score helps patients and physicians make more informed decisions about care and long-term management.